...
首页> 外文期刊>Molecular medicine. >Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.
【24h】

Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies.

机译:肥厚性瘢痕和瘢痕loid:病理机制以及当前和新兴的治疗策略。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Excessive scars form as a result of aberrations of physiologic wound healing and may arise following any insult to the deep dermis. By causing pain, pruritus and contractures, excessive scarring significantly affects the patient's quality of life, both physically and psychologically. Multiple studies on hypertrophic scar and keloid formation have been conducted for decades and have led to a plethora of therapeutic strategies to prevent or attenuate excessive scar formation. However, most therapeutic approaches remain clinically unsatisfactory, most likely owing to poor understanding of the complex mechanisms underlying the processes of scarring and wound contraction. In this review we summarize the current understanding of the pathophysiology underlying keloid and hypertrophic scar formation and discuss established treatments and novel therapeutic strategies.
机译:生理性伤口愈合异常会形成过多的疤痕,并可能在深层真皮受到任何侮辱后出现。通过造成疼痛,瘙痒和挛缩,过度的疤痕会严重影响患者的身体和心理生活质量。关于肥厚性瘢痕和瘢痕loid形成的多种研究已经进行了数十年,并且已经导致了许多预防或减轻过度的瘢痕形成的治疗策略。然而,大多数治疗方法在临床上仍然不能令人满意,很可能是由于对疤痕形成和伤口收缩过程的复杂机制了解不足。在这篇综述中,我们总结了目前对瘢痕loid和肥厚性瘢痕形成的病理生理学的了解,并讨论了已建立的治疗方法和新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号